Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

Anti-inflammatory microglial reprogramming via cystatin-C/TREM2 axis

TREM2/TYROBP · neurodegeneration · -
Composite
0.640
Price
$0.64
Evidence For
0
Evidence Against
0

Systemic tumors secrete cystatin C which crosses the BBB via LRP1 and engages TREM2 on microglia, shifting neuroinflammatory profile from pro-inflammatory (IL-1β, TNF-α, IL-6) to anti-inflammatory/regulatory (IL-10, TGF-β). This represents the most druggable pharmacology story, though the field's first major TREM2 agonist phase 2 (AL002) missed its clinical primary endpoint despite biomarker engagement. Clinical translation requires biomarker-enriched populations and likely combination therapy w

TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysregulation

TREM2/TYROBP · neurodegeneration · -
Composite
0.800
Price
$0.72
Evidence For
0
Evidence Against
0

## Mechanistic Overview TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysregulation starts from the claim that modulating TREM2/TYROBP within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) is a transmembrane glycoprotein exclusively expressed on microglia within the central nervous system, functioning as a critical

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

TREM2TYROBPBiomarkerNeuroinflammationneurodegeneration
Convergent signals
  • TREM2 recurs across 2 selected hypotheses with aligned directionality in biomarker, neuroinflammation.
  • TYROBP recurs across 2 selected hypotheses with aligned directionality in biomarker, neuroinflammation.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

1/11
dimensions won
Anti-inflammatory microglial reprogrammi
11/11
dimensions won
TREM2 Deficiency Drives Microglial Senes

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.70
0.75
Evidence
0.72
0.82
Novelty
0.55
0.65
Feasibility
0.80
0.88
Impact
0.65
0.85
Druggability
0.75
0.85
Safety
0.50
0.78
Competition
0.40
0.70
Data
0.70
0.82
Reproducible
0.65
0.80
KG Connect
0.50
0.50

Score Breakdown

DimensionAnti-inflammatory microglial rTREM2 Deficiency Drives Microg
Mechanistic0.7000.750
Evidence0.7200.820
Novelty0.5500.650
Feasibility0.8000.880
Impact0.6500.850
Druggability0.7500.850
Safety0.5000.780
Competition0.4000.700
Data0.7000.820
Reproducible0.6500.800
KG Connect0.5000.500

Evidence

Anti-inflammatory microglial reprogramming via cystatin-C/TR

No evidence citations yet

TREM2 Deficiency Drives Microglial Senescence via Lipid Meta

No evidence citations yet

Debate Excerpts

Anti-inflammatory microglial reprogramming via cys

4 rounds · quality: 0.66

Theorist

# Therapeutic Hypotheses: Cancer-Cystatin-C-TREM2 Pathway Beyond Amyloid --- ## Hypothesis 1: TREM2-Dependent Microglial Phagocytosis of Tau Seeds **Title:** Cystatin-C-activated TREM2 microglia re...

Skeptic

# Critical Evaluation of Hypotheses: Cancer-Cystatin-C-TREM2 Pathway Beyond Amyloid ## Preliminary Methodological Concerns Before evaluating individual hypotheses, several systemic issues constrain ...

Domain Expert

The key feasibility filter is the source paper itself. In the February 5, 2026 `Cell` paper, Li et al. report that peripheral cancer/CSPs reduced amyloid in `5xFAD` and `APP/PS1`, but “did not affect ...

Synthesizer

{"ranked_hypotheses":[{"title":"Anti-inflammatory microglial reprogramming via cystatin-C/TREM2 axis","description":"Systemic tumors secrete cystatin C which crosses the BBB via LRP1 and engages TREM2...

TREM2 Deficiency Drives Microglial Senescence via

4 rounds · quality: 0.79

Theorist

# Mechanistic Hypotheses: Microglial Senescence & Dystrophic Transition --- ## Hypothesis 1: mTORC1 Hyperactivation Drives Autophagic Flux Impairment and Senescence **Mechanism:** Chronic mTORC1 hy...

Skeptic

# Critical Evaluation of Mechanistic Hypotheses: Microglial Senescence & Dystrophic Transition ## Methodological Prefatory Note A rigorous skeptic's evaluation must distinguish between: (1) correlat...

Domain Expert

# Feasibility Assessment: Microglial Senescence Mechanisms for Drug Discovery ## Framing Note The SKEPTIC's revised confidence scores are adopted as the baseline for this analysis. The most defensib...

Synthesizer

{ "ranked_hypotheses": [ { "title": "TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysregulation", "description": "Loss-of-function TREM2 variants impair microgl...

Price History Overlay